ADVANCING IMMUNO-ONCOLOGY

CLINICAL TRIALS– Now Recruiting

IOVANCE is recruiting patients in four Phase 2 clinical trials to assess the efficacy and safety of autologous cell therapies for treatment of patients with cancer.

C-145-04 is a multicenter clinical trial in patients with metastatic cervical cancer at various sites in the U.S. and Europe.

IOV-LUN-202 is a Phase 2 multicenter clinical trial in patients with metastatic non-small cell lung cancer (NSCLC).

IOV-COM-202 is a multicenter clinical trial now recruiting patients with non-small cell lung cancer (NSCLC), metastatic melanoma, and head and neck squamous cell carcinoma (HNSCC) at various sites in the U.S., Canada and Europe.

IOV-CLL-01 is a clinical trial in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL).

Learn
Latest News

Sign up for email alerts

Be the first to receive breaking news

Join